Related references
Note: Only part of the references are listed.A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
Vandana Govan
Therapeutics and Clinical Risk Management (2016)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick et al.
VACCINE (2008)
Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix
Sok Cheon Pak et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2007)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
Marie-Helene Mayrand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
Silvia de Sanjose et al.
LANCET INFECTIOUS DISEASES (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L. L. Villa et al.
BRITISH JOURNAL OF CANCER (2006)
HPV DNA testing in cervical cancer screening: From evidence to policies
Tom Cox et al.
GYNECOLOGIC ONCOLOGY (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix
WAA Tjalma et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
SJ Goldie et al.
OBSTETRICS AND GYNECOLOGY (2004)
Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ
M Moberg et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Human papillomavirus infection and disease in HIV-infected individuals
ME Hagensee et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2004)
Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities
AHN Hopman et al.
JOURNAL OF PATHOLOGY (2004)
Papillomavirus vaccines in clinical trials
DA Galloway
LANCET INFECTIOUS DISEASES (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B-12
BY Hernandez et al.
CANCER CAUSES & CONTROL (2003)
A controlled trial of a human papillomavirus type 16 vaccine
LA Koutsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities - Comparison of sensitivity, specificity, and frequency of referral
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Dietary risk factors for invasive and in-situ cervical carcinomas in Bangkok, Thailand
J Shannon et al.
CANCER CAUSES & CONTROL (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
P Vassilakos et al.
BRITISH JOURNAL OF CANCER (2002)
Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control
C Scully et al.
ORAL ONCOLOGY (2000)
Share Paper
